NCT02744599
Completed
Not Applicable
Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue
ConditionsHealthy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy
- Sponsor
- University of Utah
- Enrollment
- 26
- Primary Endpoint
- Breath prompting successful rate
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
This is a small trial to test feasibility of an idea for a potential device. The investigators tested the feasibility of prompting a volunteer to breathe when their breathing had slowed down during administration of anesthetic drugs.
Investigators
Lara Brewer
Research Assistant Professor
University of Utah
Eligibility Criteria
Inclusion Criteria
- •American Society of Anesthesia (ASA) Class I and Class II male and female (non-pregnant/non-lactating) volunteers.
- •Normal healthy individual as indicated by medical history and a physical examination.
- •At least 18 years of age and less than 55 years of age.
- •Negative drug screen.
- •Uncomplicated airway anatomy.
- •A Body Mass Index between 18 and
- •Are fully informed of the risks of entering the study and willingly provide written consent to enter the trial.
- •Female subjects of child bearing potential will have a negative urine pregnancy test on the day the study is conducted.
Exclusion Criteria
- •Known or suspected neurological pathologies.
- •A history of significant alcohol or drug abuse, a history of allergy to opioids or propofol, or a history of chronic drug requirement or medical illness that is known to alter the pharmacokinetics or pharmacodynamics of remifentanil and propofol.
- •Known obstructive sleep apnea.
- •Known or suspected hypersensitivity to any compound present in the study.
- •Any potential subject suffering from medical problems that, in the judgment of the investigator, presents unacceptable risk to the volunteer are not eligible for enrollment.
- •Vulnerable subject groups such as prisoners and the mentally disabled that are traditionally excluded from medical research are also excluded.
- •The potential subject has taken any medication within 2 days prior to chosen drug administration, with the exception of oral contraceptives.
- •The potential subject is wearing artificial nails.
- •A positive urine pregnancy test (females only)
- •Female subjects who are currently lactating \& breast-feeding.
Outcomes
Primary Outcomes
Breath prompting successful rate
Time Frame: Change in respiratory rate from baseline to the period 10 seconds after the breath prompt
Similar Trials
Completed
Early Phase 1
Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical PatientsDeep Venous ThrombosisPulmonary EmbolismNCT00894283Johns Hopkins University198
Terminated
Not Applicable
Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain TumorsBrain TumorNCT00720837M.D. Anderson Cancer Center6
Completed
Not Applicable
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence DeviceUrinary Bladder, OveractiveNCT04001426FemPulse Corporation2
Active, not recruiting
Not Applicable
Brief Intervention and Fibroscan for Harmful Drinkers Presenting to the Emergency DepartmentAlcohol Use Disorder (AUD)NCT05720247Nottingham University Hospitals NHS Trust80
Recruiting
Phase 1
Prospective pilot trial to address the feasibility and safety of treatment with oral Zinc in GNAO1 associated disorders (ZINCGNAO1)GNAO1 associated disordersMedDRA version: 26.0Level: PTClassification code: 10064062Term: Neurodevelopmental disorder Class: 100000004873Therapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]CTIS2024-512735-72-00niversity Of Cologne12